Breaking News Bar
updated: 1/16/2013 8:07 AM

Greenhill hires UBS's Cuise in Chicago focusing on industrials

hello
Success - Article sent! close
 
Bloomberg News

Greenhill & Co., the independent advisory firm that added at least seven managing directors in 2012, hired UBS AG's Stephen Cruise in Chicago to focus on industrials.

Cruise, 49, was previously co-head of the Chicago office and the U.S. Midwest region for Zurich-based UBS, Greenhill said today in an e-mailed statement. He was also a senior member of the investment bank's global industrials group, New York-based Greenhill said in the statement. Before joining UBS, Cruise worked at Credit Suisse First Boston and Lehman Brothers Holdings Inc., according to the statement.

Order Reprint Print Article
 
Interested in reusing this article?
Custom reprints are a powerful and strategic way to share your article with customers, employees and prospects.
The YGS Group provides digital and printed reprint services for Daily Herald. Complete the form to the right and a reprint consultant will contact you to discuss how you can reuse this article.
Need more information about reprints? Visit our Reprints Section for more details.

Contact information ( * required )

Success - request sent close

Chief Executive Officer Scott Bok, 53, said in November that the firm experienced a "meaningful pickup" in its U.S. merger-and-acquisition business during the second half of the year. Big bank rivals are cutting employees to shed excess capacity in the financial services industry, a trend that will benefit Greenhill, he said at the time.

"Even as we expand our footprint globally, we want to develop a major presence in key U.S. regional markets, and he becomes our fifth Chicago-based partner," Bok said in the statement. Cruise's strengths are in industrial, infrastructure and energy services markets, according to the statement.

The firm said in October it hired Rupert Hill from Bank of America Corp. as a London-based managing director focusing on health care. Greenhill also added Jeffrey Wasserstein in September as a managing director for pharmaceuticals.

Greenhill fell 1.4 percent to close yesterday at $56.08 in New York. The shares have advanced 41 percent in the last year, compared with a 16 percent gain by the 83-company Standard & Poor's Midcap Financials Index.

Share this page
Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.
    help here